Judith G Villablanca

7PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 20, 2022
Expression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapy.

Shahab Asgharzadeh, Araz Marachelian, Judith G Villablanca

|May 24, 2021
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

Brian D Weiss, Gregory Yanik, Arlene Naranjo

|Jun 27, 2020
A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).

Rima F Jubran, Judith G Villablanca, Mark Krailo

|May 10, 2020
Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature.

Angela Duvalyan, Angela Cha, Fariba Goodarzian

|Apr 11, 2019
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.

Steve E Braunstein, Wendy B London, Susan G Kreissman

|Apr 01, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.

Navin Pinto, Steven G DuBois, Araz Marachelian

Pageof 2

Frequent Collaborators

2 joint publications

Katherine Matthay

2 joint publications

Barry Shulkin

2 joint publications

Araz Marachelian

1 joint publications

Navin Pinto